IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,045,517 | +29.5% | 600,300 | -36.0% | 0.06% | +31.1% |
| Q2 2023 | $17,791,963 | +36.5% | 937,900 | +11.6% | 0.04% | +32.4% |
| Q1 2023 | $13,029,951 | +92.7% | 840,100 | +120.6% | 0.03% | +78.9% |
| Q4 2022 | $6,760,975 | +255.1% | 380,900 | +11.6% | 0.02% | +216.7% |
| Q3 2022 | $1,904,000 | -9.7% | 341,300 | -36.8% | 0.01% | 0.0% |
| Q2 2022 | $2,108,000 | -46.2% | 540,400 | -24.0% | 0.01% | -40.0% |
| Q1 2022 | $3,918,000 | -37.2% | 711,000 | -2.9% | 0.01% | -37.5% |
| Q4 2021 | $6,239,000 | -28.8% | 732,300 | -27.4% | 0.02% | -30.4% |
| Q3 2021 | $8,764,000 | +0.6% | 1,008,500 | +22.4% | 0.02% | 0.0% |
| Q2 2021 | $8,710,000 | -6.5% | 824,000 | +41.9% | 0.02% | -11.5% |
| Q1 2021 | $9,311,000 | +4486.7% | 580,500 | +13093.2% | 0.03% | +2500.0% |
| Q4 2020 | $203,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |